Concarlo Therapeutics
Concarlo Therapeutics is a preclinical-stage oncology company developing transformative therapeutics to target drug-resistant cancers.
Concarlo Therapeutics is a business in cancer based in Greater New York Area, East Coast, Northeastern US, founded in 2016.
Concarlo Therapeutics is positioned in cancer, a segment that rewards a clear, focused offering.
Greater New York Area, East Coast, Northeastern US is where the company is located.
It is recorded at the Series_Unknown stage.
The company reports a headcount in the c_00001_00010 range.
Public records show total funding of about $7M.
| Sector | Cancer |
|---|---|
| Headquarters | Greater New York Area, East Coast, Northeastern US |
| Founded | 2016 |
| Employees | c_00001_00010 |
| Stage | series_unknown |
| Total funding | $7,000,000 |
Website: concarlo.com
Browse related
Sign in to view the contact information we hold for Concarlo Therapeutics.
Create a free account
Create a free account